Which statement best describes a Risk Evaluation and Mitigation Strategy (REMS)?

a.A DEA program that limits how much of a controlled substance a pharmacy may order each month
b.An FDA-required safety program that may mandate prescriber certification, patient enrollment, pharmacy certification, or laboratory monitoring before a drug is dispensed
c.A USP standard that sets beyond-use dates for compounded preparations
d.A manufacturer's voluntary coupon program that lowers patient copays for specialty drugs

Giải thích

A REMS is imposed by the FDA when a drug's serious safety risks require controls beyond standard labeling, and its elements can include certifying prescribers and pharmacies, enrolling patients in a registry, and documenting laboratory results before dispensing. Familiar examples are iPLEDGE for isotretinoin, absolute neutrophil count monitoring for clozapine, and the restricted program for thalidomide. Ordering quotas are a DEA function, beyond-use dating is set by USP compounding standards, and copay assistance has no regulatory safety role.

Trích dẫn luật: FDA REMS (FDAAA 2007)

Luyện miễn phí toàn bộ 100 câu hỏi — không cần đăng ký.

Câu hỏi liên quan cùng chủ đề

Cập nhật gần nhất: · quy trình kiểm tra

Đội Ngũ Biên Tập PrepPass · Đối chiếu với PTCB Pharmacy Technician Certification Exam (PTCE) · Quy trình kiểm tra
Báo lỗi